Dexrazoxane and Insulin Aspart (Vials) (Fiasp)
Determining the interaction of Dexrazoxane and Insulin Aspart (Vials) (Fiasp) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: dexrazoxane
Brand name: Totect, Zinecard
Synonyms: n.a.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Dexrazoxane-Insulin aspart and insulin aspart protamine
- Dexrazoxane-Insulin aspart and insulin degludec Subcutaneous
- Dexrazoxane-Insulin Aspart Injection
- Dexrazoxane-Insulin Aspart Protamine and Insulin Aspart
- Dexrazoxane-Insulin aspart protamine and insulin aspart Subcutaneous
- Dexrazoxane-Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens)
- Insulin Aspart (Vials) (Fiasp)-Dexrazoxane Hydrochloride
- Insulin Aspart (Vials) (Fiasp)-Dexrazoxane Intravenous
- Insulin Aspart (Vials) (Fiasp)-Dextenza Insert
- Insulin Aspart (Vials) (Fiasp)-Dextenza intraocular
- Insulin Aspart (Vials) (Fiasp)-Dextran 40
- Insulin Aspart (Vials) (Fiasp)-Dextran 70 6% in 5% Dextrose high molecular weight